Literature DB >> 23727455

Intellectual functioning and multi-dimensional attentional processes in long-term survivors of a central nervous system related pediatric malignancy.

Robert W Butler1, Diane L Fairclough, Ernest R Katz, Anne E Kazak, Robert B Noll, Ryan D Thompson, Olle Jane Z Sahler.   

Abstract

AIMS: Central nervous system (CNS) malignancies and/or their treatment in pediatric cancer survivors are known to be associated with deficits in neuropsychological functions. We report findings from a nation-wide study of childhood cancer survivors to investigate intelligence and attention/concentration from a multi-dimensional perspective in a diverse sample from this population. MAIN
METHODS: Four hundred forty-four pediatric cancer survivors between 6 and 17 years of age, who had suffered CNS involvement associated with their malignancy, were evaluated. All patients completed a measure of general intelligence. Attention was measured by a continuous performance test (CPT) and by parental report using a standardized psychological inventory. KEY
FINDINGS: Social economic status (SES) was a significant predictor of intellectual functioning and scores on independent measures of attention. After controlling for SES, cranial radiation therapy (CRT) was strongly predictive of impairments in intellectual functioning. Patients who had completed a transplant procedure did not have significant impairments in intellectual functioning when compared to other participants. CPT performance was most clearly influenced by a younger age at diagnosis and the presence of a supratentorial brain tumor. Reaction time was lower in patients who had received CRT. Gender did not correlate with CPT performance, but caregiver reports of deficits in attentional functioning were more prevalent in girls compared to boys. SIGNIFICANCE: These findings are important given the large, representative sample and multi-dimensional assessment of attentional functioning. The presence of a very strong SES effect on all dependent variables must be addressed in studies of this nature.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Attention; Intelligence; Pediatric cancer survivors; Socio-economic status

Mesh:

Year:  2013        PMID: 23727455     DOI: 10.1016/j.lfs.2013.05.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Health and well-being in adolescent survivors of early childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Ann C Mertens; Sarah Brand; Kirsten K Ness; Zhenghong Li; Pauline A Mitby; Anne Riley; Andrea Farkas Patenaude; Lonnie Zeltzer
Journal:  Psychooncology       Date:  2013-10-04       Impact factor: 3.894

2.  The potential utility of parent-reported attention screening in survivors of childhood cancer to identify those in need of comprehensive neuropsychological evaluation.

Authors:  Kristina K Hardy; Victoria W Willard; Alissa B Wigdor; Taryn M Allen; Melanie J Bonner
Journal:  Neurooncol Pract       Date:  2014-12-12

3.  Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.

Authors:  Amanda L Winter; Heather M Conklin; Vida L Tyc; Heather Stancel; Pamela S Hinds; Melissa M Hudson; Lisa S Kahalley
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-15       Impact factor: 2.475

4.  Maintenance of Tight Junction Integrity in the Absence of Vascular Dilation in the Brain of Mice Exposed to Ultra-High-Dose-Rate FLASH Irradiation.

Authors:  Barrett D Allen; Munjal M Acharya; Pierre Montay-Gruel; Patrik Goncalves Jorge; Claude Bailat; Benoît Petit; Marie-Catherine Vozenin; Charles Limoli
Journal:  Radiat Res       Date:  2020-12-01       Impact factor: 2.841

5.  Determinants of social competence in pediatric brain tumor survivors who participated in an intervention study.

Authors:  Maru Barrera; Eshetu G Atenafu; Fiona Schulte; Ute Bartels; Lillian Sung; Laura Janzen; Joanna Chung; Danielle Cataudella; Kelly Hancock; Amani Saleh; Douglas Strother; Dina McConnell; Andrea Downie; Juliette Hukin; Shayna Zelcer
Journal:  Support Care Cancer       Date:  2017-04-14       Impact factor: 3.603

Review 6.  Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life.

Authors:  Priyamvada Gupta; Rakesh Jalali
Journal:  Curr Neurol Neurosci Rep       Date:  2017-11-08       Impact factor: 5.081

7.  Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.

Authors:  Kristina K Hardy; Leanne Embry; John A Kairalla; Shanjun Helian; Meenakshi Devidas; Daniel Armstrong; Stephen Hunger; William L Carroll; Eric Larsen; Elizabeth A Raetz; Mignon L Loh; Wenjian Yang; Mary V Relling; Robert B Noll; Naomi Winick
Journal:  J Clin Oncol       Date:  2017-07-03       Impact factor: 44.544

8.  Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Authors:  Lisa M Jacola; Julie Baran; Robert B Noll; Victoria W Willard; Kristina K Hardy; Leanne Embry; Stephanie E Hullmann; Eric C Larsen; Naomi Winick; John A Kairalla
Journal:  Pediatr Blood Cancer       Date:  2021-01-31       Impact factor: 3.167

9.  The impact of socioeconomic status (SES) on cognitive outcomes following radiotherapy for pediatric brain tumors: a prospective, longitudinal trial.

Authors:  Victoria A Torres; Jason M Ashford; Evelyn Wright; Jiahui Xu; Hui Zhang; Thomas E Merchant; Heather M Conklin
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

10.  Predictors of cognitive function in pediatric brain tumor patients: Pre-surgery through 24-month follow-up.

Authors:  Claire E Fraley; Jennifer C Thigpen; Matthew M Pearson; John F Kuttesch; Leandra Desjardins; Kristen R Hoskinson; Abraham Alvarado-Gonzalez; Adam J Esbenshade; Devang Pastakia; Debra L Friedman; John C Wellons; Colleen M McNally; Rachel E Siciliano; Bruce E Compas
Journal:  Appl Neuropsychol Child       Date:  2019-12-30       Impact factor: 1.613

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.